BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 32248820)

  • 1. Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol.
    Bulteau S; Laurin A; Volteau C; Dert C; Lagalice L; Schirr-Bonnans S; Bukowski N; Guitteny M; Simons L; Cabelguen C; Pichot A; Tessier F; Bonnin A; Lepage A; ; ; Vanelle JM; Sauvaget A; Riche VP
    Trials; 2020 Apr; 21(1):312. PubMed ID: 32248820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario.
    Fitzgibbon KP; Plett D; Chan BCF; Hancock-Howard R; Coyte PC; Blumberger DM
    Can J Psychiatry; 2020 Mar; 65(3):164-173. PubMed ID: 31801363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) Veteran patients: study protocol for a randomized controlled trial.
    Mi Z; Biswas K; Fairchild JK; Davis-Karim A; Phibbs CS; Forman SD; Thase M; Georgette G; Beale T; Pittman D; McNerney MW; Rosen A; Huang GD; George M; Noda A; Yesavage JA
    Trials; 2017 Sep; 18(1):409. PubMed ID: 28865495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model.
    Vallejo-Torres L; Castilla I; González N; Hunter R; Serrano-Pérez P; Perestelo-Pérez L
    Psychol Med; 2015 May; 45(7):1459-70. PubMed ID: 25354790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
    McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
    Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(4):1-232. PubMed ID: 34055112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT.
    Brunelin J; Jalenques I; Trojak B; Attal J; Szekely D; Gay A; Januel D; Haffen E; Schott-Pethelaz AM; Brault C; ; Poulet E
    Brain Stimul; 2014; 7(6):855-63. PubMed ID: 25192980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: A cost analysis.
    Mendlowitz AB; Shanbour A; Downar J; Vila-Rodriguez F; Daskalakis ZJ; Isaranuwatchai W; Blumberger DM
    PLoS One; 2019; 14(9):e0222546. PubMed ID: 31513675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, sham-controlled study of maintenance rTMS for treatment-resistant depression (TRD).
    Benadhira R; Thomas F; Bouaziz N; Braha S; Andrianisaina PS; Isaac C; Moulier V; Januel D
    Psychiatry Res; 2017 Dec; 258():226-233. PubMed ID: 28844559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance repetitive transcranial magnetic stimulation (rTMS) therapy for treatment-resistant depression: a study protocol of a multisite, prospective, non-randomized longitudinal study.
    Yamazaki R; Matsuda Y; Oba M; Oi H; Kito S
    BMC Psychiatry; 2023 Jun; 23(1):437. PubMed ID: 37322460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of transcranial direct current stimulation (tDCS) in non-treatment-resistant depression: the DISCO randomised controlled study protocol.
    Sauvaget A; Lagalice L; Schirr-Bonnans S; Volteau C; Péré M; Dert C; Rivalland A; Tessier F; Lepage A; Tostivint A; Deschamps T; Thomas-Ollivier V; Robin A; Pineau N; Cabelguen C; Bukowski N; Guitteny M; Beslot A; Simons L; Network H; Vanelle JM; D'Urso G; Bulteau S; Riche VP;
    BMJ Open; 2020 Jan; 10(1):e033376. PubMed ID: 31937653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rTMS combined with CBT as a next step in antidepressant non-responders: a study protocol for a randomized comparison with current antidepressant treatment approaches.
    Dalhuisen I; Smit F; Spijker J; van Oostrom I; van Exel E; van Mierlo H; de Waardt D; Arns M; Tendolkar I; van Eijndhoven P
    BMC Psychiatry; 2022 Feb; 22(1):88. PubMed ID: 35123427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness Modeling of Repetitive Transcranial Magnetic Stimulation Compared to Electroconvulsive Therapy for Treatment-Resistant Depression in Singapore.
    Zhao YJ; Tor PC; Khoo AL; Teng M; Lim BP; Mok YM
    Neuromodulation; 2018 Jun; 21(4):376-382. PubMed ID: 29143405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent theta burst stimulation (iTBS) versus 10 Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) to alleviate treatment-resistant unipolar depression: A randomized controlled trial (THETA-DEP).
    Bulteau S; Laurin A; Pere M; Fayet G; Thomas-Ollivier V; Deschamps T; Auffray-Calvier E; Bukowski N; Vanelle JM; Sébille V; Sauvaget A
    Brain Stimul; 2022; 15(3):870-880. PubMed ID: 35609816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.